March 18, 2021

Within3 in MedCityNews

While Covid-19 temporarily paused our ability to interact face-to-face, it also ushered in an era of global collaboration and the ability for life science teams to make decisions based on an expanded viewpoint.

MedCityNews featured what might be the silver lining of last year’s global challenges in an article by Natalie DiMambro, Vice President of Learning and Development at Within3. During travel restrictions and widespread lockdowns, life science teams were left with little choice when it came to interacting – it had to be virtual – but discovered newfound freedom when it came to who could sit around the virtual conference table.

Read the entire article

Related Posts:

pharma and women's health

Within3 in Journal of mHealth: how can pharma address gender inequality in healthcare?

Life science companies can use technology to correct drug development and healthcare inequalities.
medical affairs data management

Within3 in PM360

The pitfalls of medical affairs data management and what the future might hold for teams that can adapt.

Within3 Appoints Erin Mistry as Chief Executive Officer

Global biopharma executive and commercial strategist to lead the company’s next chapter of growth